PMC3273852_01
Whole-body scan with 177Lu-DOTATATE performed 3 months before pregnancy and after the 6th cycle of PRRT (A) and after the 8th cycle of PRRT (B).
can-6-240f1.jpg
PMC3273852_01_can-6-240f1.jpg
f1-can-6-240
Three months after the sixth cycle of PRRT, (cumulative activity dose 22.42 GBq - 606 mCi) (Figure 1A) an unplanned pregnancy was found. Octreotide LAR was reintroduced with disease stabilization (Figure 1B). On her last clinical examination, 8 years after diagnosis, the patient, in good clinical condition, firmly expressed her desire to have a child in the next future, although she had concerns about the risk of symptoms worsening and flushing recurrence, as experienced in her previous gestation.